Probiotics: A possible role in treatment of adult and pediatric non alcoholic fatty liver disease

Annals of Hepatology

Volumn 12, Issue 1, 2013, Pages 161-163

  Vajro, Pietro ^a   Mandato, Claudia ^b   Veropalumbo, Claudio ^c   De Micco, Ida ^c  

^a UNIVERSITY OF SALERNO   (Italy)

^b SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; PREBIOTIC AGENT; PROBIOTIC AGENT;

ADULT; BACTERIAL STRAIN; DIET THERAPY; EVIDENCE BASED MEDICINE; HUMAN; INTESTINE FLORA; LACTOBACILLUS BULGARICUS; LETTER; LIFESTYLE MODIFICATION; LIVER DYSFUNCTION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; STREPTOCOCCUS THERMOPHILUS; ANIMAL; BACTERIUM; FATTY LIVER; GROWTH, DEVELOPMENT AND AGING; INTESTINE; MICROBIOLOGY; NOTE;

ANIMALS; BACTERIA; FATTY LIVER; HUMANS; INTESTINES;

EID: 84878758615     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31401-2     Document Type: Letter

References (8)

1. Machado MV, Cortez-Pinto H. Gut microbiota and nonalcoholic fatty liver disease. Ann Hepatol 2012; 11: 440-9.
2. Loguercio C, De Simone T, Federico A, Terracciano F, Tuccillo C, Di Chicco M, Cartenì M. Gut-liver axis: a new point of attack to treat chronic liver damage? Am J Gastroenterol 2002; 97: 2144-6.
3. Loguercio C, Federico A, Tuccillo C, Terracciano F, D'Auria MV, De Simone C, Del Vecchio Blanco C. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol 2005; 39: 540-3.
4. Lirussi F, Mastropasqua E, Orando S, Orlando R. Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst Rev 2007; CD005165.
5. Socha P, Horvath A, Vajro P, Dziechciarz P, Dhawan A, Szajewska H. Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review. J Pediatr Gastroenterol Nutr 2009; 48: 587-96.
6. Aller R, De Luis DA, Izaola O, Conde R, Gonzalez Sagrado M, Primo D, et al. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci 2011; 15: 1090-5.
7. Vajro P, Mandato C, Licenziati MR, Franzese A, Vitale DF, Lenta S, Caropreso M, et al. Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease. J Pediatr Gastroenterol Nutr 2011; 52: 740-3.
8. Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, De Vincenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 1994; 125: 239-41.